KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Cash & Current Investments (2016 - 2025)

Eli Lilly (LLY) has disclosed Cash & Current Investments for 17 consecutive years, with $7.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments rose 112.34% year-over-year to $7.3 billion, compared with a TTM value of $7.3 billion through Dec 2025, up 112.34%, and an annual FY2025 reading of $7.3 billion, up 112.34% over the prior year.
  • Cash & Current Investments was $7.3 billion for Q4 2025 at Eli Lilly, down from $9.9 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $9.9 billion in Q3 2025 and bottomed at $2.2 billion in Q4 2022.
  • Average Cash & Current Investments over 5 years is $3.7 billion, with a median of $3.2 billion recorded in 2021.
  • The sharpest move saw Cash & Current Investments tumbled 43.41% in 2022, then surged 181.76% in 2025.
  • Year by year, Cash & Current Investments stood at $3.9 billion in 2021, then plummeted by 43.41% to $2.2 billion in 2022, then surged by 32.37% to $2.9 billion in 2023, then grew by 16.91% to $3.4 billion in 2024, then soared by 112.34% to $7.3 billion in 2025.
  • Business Quant data shows Cash & Current Investments for LLY at $7.3 billion in Q4 2025, $9.9 billion in Q3 2025, and $3.5 billion in Q2 2025.